D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 122,700
-2,700 (-2.15%)
Jun 27, 2025, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.42 trillion as of June 27, 2025. Its market cap has increased by 290.66% in one year.
Market Cap
1.42T
Enterprise Value
1.40T
Revenue
10.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
122,700.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.42T, an increase of 274.61%. That is a compound annual growth rate of 222.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 1,421.87B | 176.84% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.46T |
| Celltrion | 35.49T |
| ALTEOGEN | 20.84T |
| Yuhan | 7,589.05B |
| SK Biopharmaceuticals | 7,236.14B |
| HLB Co., Ltd. | 6,512.41B |
| PharmaResearch | 4,992.23B |
| Peptron | 4,741.01B |